
Bloom Energy Corp
Electrical Equipment
Bloom Energy Corp (BE) Stock News
The latest BE headlines and market coverage — 17 recent stories, updated throughout the day.
- Benzinga·Neutral
HYDAWAY DIGITAL APPOINTS CYBER SECURITY INDUSTRY VETERAN TO ADVISORY BOARD
Hydaway Digital Corp. announced the appointment of Angelo Valentini, Head of Channel Sales at Check Point Software Technologies, as a strategic advisor. Valentini will help advance Hydaway's RealityChek cybersecurity platform and advise on strategic initiatives related to cybersecurity and deepfakes detection.
- GlobeNewswire Inc.·
T1 Energy to Enter BESS and Data Center Infrastructure Markets with Acquisition of KORE Power
T1 Energy Inc. announced a definitive agreement to acquire KORE Power, Inc. for approximately $32 million in enterprise value, with an additional $9.6 million in potential equity-based earn-outs. The acquisition is expected to close in Q2 2026 and will rebrand KORE Power as T1 NRI, providing T1 entry into the battery energy storage systems and AI data center infrastructure markets. The transaction is projected to be EBITDA accretive, generating positive EBITDA in 2026 and contributing $15-20 million in 2027.
- GlobeNewswire Inc.·
SIKA APPOINTS NEW MEMBER OF GROUP MANAGEMENT AND ADVANCES DIGITAL TRANSFORMATION
Sika has appointed Philipp Irniger as Head of Construction and Group Management member, effective June 1, 2026, succeeding Ivo Schädler who is retiring. Additionally, Sika created a new Chief Digital & Information Officer position to accelerate its digital transformation strategy and strengthen its digital leadership in the industry.
- Benzinga·
Stock Market Today: S&P 500, Dow, Nasdaq Futures Rise As US Undertakes 'Self-Defense' Strikes Against Iran— HPE, NVDA, UBER In Focus (UPDATED)
Editor’s Note: The future prices of benchmark tracking ETFs, and the headline were updated in the story. U.S. stock futures rose on Monday, after a higher close on Friday, ending the month of May at a record high. The U.S. has undertaken "self-defense" strikes in Iran on Sunday as President Donald Trump says Iran wants a deal and urges critics to stop second-guessing his negotiation strategy. According to an update on X by the Central Command, the U.S. carried out strikes in Iran over the weekend, hitting Iranian radar and command and control sites. The strikes were in response to "aggressive Iranian actions," including the shooting down of a US MQ-1 drone operating over international waters. Investors will keep an eye on the May jobs report this week, slated for a Friday release, and earnings from tech heavyweights like Palo Alto Networks Inc. (NASDAQ: PANW ) , CrowdStrike Holdings Inc. (NASDAQ: CRWD ) , and Broadcom Inc. (NASDAQ: AVGO ) . Meanwhile, the 10-year Treasury bond yielded 4.46%, and the two-year bond was at 4.03%. The CME Group's FedWatch tool ‘s projections show markets pricing a 99.4% likelihood of the Federal Reserve leaving the current interest rates unchanged during June’s meeting. Index Performance (+/-) Dow Jones 0.15% S&P 500 0.15% Nasdaq 100 0.18% Russell 2000 -0.10% The SPDR S&P 500 ETF Trust (NYSE: SPY ) and Invesco QQQ Trust ETF (NASDAQ: QQQ ) , which track the S&P 500 and Nasdaq 100, respectively, were higher in premarket on Monday. The SPY was up 0.22% at $758.04, while the QQQ was higher by 0.21% to $739.86. data-variant="card" data-news-mode="manual" > Read Also: Stock Market: Will S&P 500 Open Up Or Down Today? Stocks In Focus Hewlett Packard Enterprise Hewlett Packard Enterprise Co. (NYSE: HPE ) jumped 6.06% in premarket on Friday as it is set to report its second-quarter results after market close.
- Benzinga·
ALLIANCEBERNSTEIN GLOBAL HIGH INCOME FUND, INC. REPORTS FOURTH QUARTER EARNINGS
NEW YORK , May 29, 2026 /PRNewswire/ -- AllianceBernstein Global High Income Fund, Inc. (NYSE: AWF ), a registered closed‑end investment company, today announced earnings for the fourth quarter ended March 31, 2026. Total net assets of the Fund on March 31, 2026 were $963,393,828 as compared with $985,227,126 on December 31, 2025 and $966,409,431 on March 31, 2025. On March 31, 2026, the net asset value per share was $11.17 based on 86,229,677 shares of common stock outstanding. March 31, 2026 December 31, 2025 March 31, 2025 Total Net Assets $963,393,828 Full story available on Benzinga.com
- GlobeNewswire Inc.·Neutral
Dimensional Fund Advisors Ltd. : Form 8.3 - BEAZLEY PLC - Ordinary Shares
Dimensional Fund Advisors Ltd. has disclosed a 2.05% interest in Beazley PLC, comprising 12,315,078 ordinary shares as of May 28, 2026. The disclosure includes a sale of 44,449 shares at 12.81 GBP per unit and a transfer in of 2,245 shares. Dimensional expressly disclaims beneficial ownership and notes it lacks discretion over 229,417 of the shares disclosed.
- GlobeNewswire Inc.·
Infinite Grid Capital Signs 1.1 GWh BESS Supply LOI with NeoVolta to Power U.S. AI Infrastructure Buildout
Infinite Grid Capital has signed a non-binding Letter of Intent with NeoVolta for the procurement of 1.1 GWh of utility-scale battery energy storage systems manufactured at NeoVolta's Georgia facility. The agreement covers three projects totaling approximately 1.1 GWh across West Texas, Puerto Rico, and PJM territory, with production expected to begin in Q3 2026. This represents the first commercial LOI for NeoVolta's Pendergrass facility and follows IGC's $13 million strategic investment in NeoVolta in December 2025.
- Benzinga·
MERGER BETWEEN RICHMOND MUTUAL BANCORPORATION, INC. AND THE FARMERS BANCORP, FRANKFORT, INDIANA RECEIVES SHAREHOLDER APPROVAL
Richmond Mutual Bancorporation, Inc. and The Farmers Bancorp have received necessary shareholder approvals for their planned merger. Farmers Bancorp shareholders will receive 3.40 shares of Richmond Mutual common stock for each share owned. The transaction is expected to close by end of Q2 2026. The combined company will operate as Richmond Mutual Bancorporation, Inc. on Nasdaq under ticker RMBI, with the bank operating as First Bank Midwest.
- GlobeNewswire Inc.·
Olema Oncology Announces Clinical Trial Collaboration and Supply Agreement with Bayer to Evaluate OP-3136 in Combination with NUBEQA® (darolutamide) in Metastatic Castration-Resistant Prostate Cancer
Olema Oncology announced a clinical trial collaboration with Bayer to evaluate OP-3136, a KAT6 inhibitor, in combination with darolutamide in approximately 36 patients with metastatic castration-resistant prostate cancer. The Phase 1b/2 study is expected to initiate in H2 2026 and represents the first clinical collaboration for OP-3136. Olema will lead the study while maintaining full global commercial rights to OP-3136, with clinical data and inventions jointly owned.
- Benzinga·
MEDX HOLDINGS (MEDH) REPORTS EXCEPTIONAL Q1 2026 FINANCIALS: REVENUE SURGES, EXPANSION ON TRACK, AND CEO TO SPEAK AT HEMP BEVERAGE EXPO
Austin, Texas , May 26, 2026 (GLOBE NEWSWIRE) -- FOR IMMEDIATE RELEASE MEDX HOLDINGS (MEDH) REPORTS EXCEPTIONAL Q1 2026 FINANCIALS: REVENUE SURGES, EXPANSION ON TRACK, AND CEO TO SPEAK AT HEMP BEVERAGE EXPO AUSTIN, Texas — May 26, 2026 — MedX Holdings, Inc. (OTC: MEDH ) (soon to be Dazed Inc., pending ticker symbol DAZE), a dynamic brands and acquisition company focused on the emerging hemp, cannabis, and hospitality industries, today announced its financial results for the first quarter ended March 31, 2026. The company is thrilled to report significant year-over-year revenue and gross profit growth, continued profitability, and major traction in its nationwide franchise expansion. Q1 2026 Financial Highlights: Accelerated Growth and Profitability The first quarter of 2026 reflects the power of MedX's strategic focus on high-margin branding, efficient operations, and calculated expansion. Key financial milestones from the Q1 2026 consolidated financial statements include: Solid Revenue Growth: Q1 2026 revenues reached $521,874, representing an impressive 52.7% increase compared to revenues of $341,711 in Q1 2025. Surging Gross Profit: Gross profit for the quarter climbed to $398,990, a 70.6% jump from the $233,793 reported in the same period last year. Sustained Profitability: The company maintained a positive bottom line, reporting a net income of $22,203 for the three months ended March 31, 2026. Expansion on Track: Bringing the "Third Place" to New Cities Following the momentum built in late 2025, ... Full story available on Benzinga.com
- Benzinga·
ALLIANCEBERNSTEIN CLOSED-END FUNDS ANNOUNCE DISTRIBUTION RATES
AllianceBernstein announced distribution rates for two of its closed-end funds. The AllianceBernstein Global High Income Fund (AWF) declared a distribution of $0.0655 per share, while the AllianceBernstein National Municipal Income Fund (AFB) declared $0.05018 per share, both with an ex-date of June 4, 2026 and payment date of June 26, 2026.
- Benzinga·
IMPERIAL PETROLEUM INC. Reports Q1 26 results, SECOND BEST QUARTERLY results in its history
ATHENS, Greece, May 22, 2026 (GLOBE NEWSWIRE) -- IMPERIAL PETROLEUM INC. (NASDAQ: IMPP , the "Company")), a ship-owning company providing petroleum products, crude oil and dry bulk seaborne transportation services, announced today its unaudited financial and operating results for the first quarter ended March 31, 2026. OPERATIONAL AND FINANCIAL HIGHLIGHTS Fleet operational utilization of 88.7% in Q1 26' compared to 91.8% in Q4 25' and 83.8% in Q1 25'. Approximately 59% of total fleet calendar days in Q1 26' were dedicated to time charter activity while approximately 39% to spot activity. Delivery of the dry bulk carrier, Eco Crossfire, on April 3, 2026 which increased our fleet on the water to 21 vessels; the remaining four contracted dry bulk carriers and one tanker are scheduled to be delivered by end of Q3 26' bringing our total fleet to 26 ships. In Q1 26' Imperial Petroleum marked its second- best quarterly performance. Revenues of $61.7 million in Q1 26' compared to $51.1 million in Q4 25' and $32.1 million in Q1 25', representing a 20.7% increase and a 92.2% increase, respectively. Impressive increase of our operating income to $26.5 million in Q1 26', marking a $12.8 million or 93.4% increase compared to Q4 25' and a $18.7 million or 239.7% increase compared to Q1 25'. Net income generation of $28.0 million in Q1 26'- the second best in our history- compared to $15.0 million in Q4 25', and $11.3 million in Q1 25', representing a 86.7% and 147.8% increase, respectively. Basic EPS of $0.60 in Q1 26'. EBITDA 1 of $34.4 million for Q1 26'. Continued enhancement of our liquidity through efficient vessel operations; cash and cash equivalents including time deposits of $212.6 million as of March 31, 2026 compared to $179.1 million as of December 31, 2025. Under the $10 million stock
- Benzinga·
METALLIUM DESCRIBES COMPANY'S METAL PROCESSING TECHNOLOGY TO COMBAT THE 'WEAPONIZATION OF THE PERIODIC TABLE' AND HALT RELIANCE ON CHINA DURING PRESENTATION AT CANACCORD GENUITY 5th ANNUAL GLOBAL METALS AND MINING CONFERENCE IN NEVADA
Metallium Limited presented its patented Flash Joule Heating (FJH) technology at the Canaccord Genuity Global Metals and Mining Conference, positioning it as a solution to reduce U.S. reliance on China for critical metals processing. The company, which recently received a Department of War grant for gallium and germanium recovery from e-waste, is pursuing a NASDAQ uplist expected later in 2026 and focusing on urban mining/recycling and mineral processing verticals.
- GlobeNewswire Inc.·
THE PARC DES PRINCES AS YOU’VE NEVER SEEN IT BEFORE - Paris Saint-Germain Legends, VIP Guests and Members of ALL Accor gather for the “Dream Tournament” - An experience by ALL Accor
ALL Accor, Accor's loyalty platform, hosted an immersive 'Dream Tournament' event at Paris Saint-Germain's Parc des Princes stadium on May 18, 2026, allowing over 160 members to experience a day as PSG players alongside club legends. The event featured activations from Accor's 45+ brands and concluded with an after-party headlined by DJ duo Ofenbach. ALL Accor and PSG extended their partnership through 2030.
- GlobeNewswire Inc.·
Beam Therapeutics Presents Recently Reported Topline Clinical Data for BEAM-302 in Alpha-1 Antitrypsin Deficiency (AATD) at the American Thoracic Society (ATS) 2026 International Conference
Beam Therapeutics presented additional clinical data from its Phase 1/2 BEAM-302 trial for alpha-1 antitrypsin deficiency (AATD) at the American Thoracic Society conference. The data from 29 patients showed durable efficacy, improved safety profile, and reduction in neutrophil elastase activity. The company plans to pursue an accelerated FDA approval pathway and expects to initiate a pivotal cohort with approximately 50 additional patients in the second half of 2026.
- Benzinga·
SEEGNAL INC. ANNOUNCES FILING OF 2025 ANNUAL FILINGS AND THAT THE MCTO WILL NO LONGER BE IN EFFECT AS OF MAY 16, 2026
CALGARY, AB, May 17, 2026 (GLOBE NEWSWIRE) -- Seegnal Inc. (TSXV: SEGN ) (" Seegnal " or the " Company ") announces that the management cease trade order (the " MCTO "), issued by the Alberta Securities Commission on May 8, 2026, at the request of the Company, will no longer be in effect as of May 16, 2026. On May 13, 2026, the Company filed its audited consolidated financial statements for the year ended December 31, 2025, together with the related management's discussion and analysis and the Chief Executive Officer and the Chief Financial Officer certifications. The MCTO applied only to the Chief Executive Officer and the Chief Financial Officer and did not affect the ability of the general investing public to trade in the Company's securities. The Company confirms that it is current with its continuous disclosure obligations and anticipates meeting its future filing requirements. About Seegnal Seegnal is a public company that aims to solve one of the top causes of death and injuries in the modern world – Adverse Drug Effects (ADEs). Seegnal's Clinical Decision Support system introduces a paradigm shift in the approach to this problem by implementing a new elevated Patient-Centric Standard. Seegnal's SaaS technology exclusively integrates at the point-of-care, unique patient-specific data like genetics, results of lab tests, ECG, smoking, allergies, food, gender, age, and the effects of many concomitant medications, while reducing the current alert load for clinicians ... Full story available on Benzinga.com
- GlobeNewswire Inc.·
FAU BEPI Poll: Hispanic Consumer Confidence Drops Sharply in First Quarter
Hispanic consumer sentiment declined significantly in Q1 2026, with the Hispanic Consumer Sentiment Index falling from 85.8 to 73.94. A majority now report worsening financial situations, reduced expectations for economic improvement, and decreased willingness to make major purchases like homes and vehicles.